Last year, Exelixis Inc generated 2.11B USD for its biggest-performing segment, CABOMETYX. The U.S made the largest contribution, accounting for 2.14B USD last year. For the latest quarter, Exelixis Inc reported the revenue of 570.65M USD for the period ending 2026-06-30, which came from the top-performing segment, CABOMETYX. U.S contributed the highest revenue, at 578.36M USD.